Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA] - N0000193914
Pharmacologic Class Information
| Pharmacologic Code | N0000193914 |
| Pharmacologic Name | Adenosine Triphosphate-Citrate Lyase Inhibitors |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Adenosine Triphosphate-Citrate Lyase Inhibitors
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 72426-118 | Nexletol | Non-Proprietary Name: Bempedoic Acid | Tablet, Film Coated | Oral | Esperion Therapeutics, Inc. | ACTIVE | |
| 72426-818 | Nexlizet | Non-Proprietary Name: Bempedoic Acid And Ezetimibe | Tablet, Film Coated | Oral | Esperion Therapeutics, Inc. | ACTIVE |